Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$619K Buy
3,174
+1,069
+51% +$222K 0.02% 374
2026
Q1
$473K Buy
2,105
+7
+0.3% +$1.74K 0.03% 379
2025
Q4
$505K Sell
2,098
-4
-0.2% -$1.02K 0.04% 354
2025
Q3
$575K Buy
+2,102
New +$574K 0.05% 359

Other funds holding RMD

Tema ETFs's RMD Position: Q2 2026 in Review

Tema ETFs increased its ResMed (RMD) stake by 51% in Q2 2026, buying an estimated $222K and bringing the position to 3,174 shares worth $619K. The position accounts for 0.02% of the portfolio, ranked #374.

Tema ETFs first reported a position in RMD in Q3 2025 and has held it in 4 quarters since. 126 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Tema ETFs held 3,174 shares of ResMed worth $619K as of Q2 2026.
  • Tema ETFs bought 1,069 ResMed shares in Q2 2026, an estimated $222K.
  • ResMed made up 0.02% of Tema ETFs's portfolio in Q2 2026, its #374 holding.
  • Tema ETFs first reported a position in ResMed in Q3 2025 and has held it in 4 quarters since.
  • 126 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.